Nova Financial’s Unicycive Therapeutics UNCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.27K Buy
+910
New +$4.72K ﹤0.01% 676

Other funds holding UNCY

Nova Financial's UNCY Position: Q3 2026 in Review

Nova Financial opened a new position in Unicycive Therapeutics (UNCY) in Q3 2026: 910 shares worth $4.27K. The stake represents ﹤0.01% of the portfolio and ranks #676 among its holdings.

91 funds tracked by Wall St. Rank hold UNCY as of Q3 2026.

  • Nova Financial held 910 shares of Unicycive Therapeutics worth $4.27K as of Q3 2026.
  • Unicycive Therapeutics was a new Nova Financial position in Q3 2026.
  • Unicycive Therapeutics made up ﹤0.01% of Nova Financial's portfolio in Q3 2026, its #676 holding.
  • 91 funds tracked by Wall St. Rank held Unicycive Therapeutics as of Q3 2026.

Based on Nova Financial's 13F filing for Q3 2026, filed 4 Nov 2026.